Full Press Release Details
GAITHERSBURG, Md., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a pioneer in drug-eluting biomatrix technologies, today announced that Dr. Randy Mills, President and Chief Executive Officer, will present at the LD Micro Main Event XIX Conference in San Diego on Tuesday, October 21, 2025, at 1:00 p.m. PT (4:00 p.m. ET).
LD Micro Main Event XIX ConferencePresentation Date:Tuesday, October 21, 2025Presentation Time:1:00 p.m. PT (4:00 p.m. ET)Webcast:Click here
Elutia management will also participate in 1x1 investor meetings. Institutional investors interested in scheduling a meeting may contact an LD Micro representative or emailIR@elutia.com.
About ElutiaElutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia’s mission is humanizing medicine so patients can thrive without compromise. For more information, visitwww.Elutia.com.
Investors:Matt SteinbergFINN Partnersmatt.steinberg@finnpartners.com
This press release was published by a CLEAR® Verified individual.